Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 967-971

  Marco, A ^a   Cayla J A ^b   Serra, M ^a   Pedro, R ^b   Sanrama, C ^a   Guerrero, R ^c   Ribof, N ^d   Fernandez J ^e   Boguna J ^e   Mercade E ^e   Torralba, L I ^f   Magri N ^f   Vazquez J M ^f   Serres, E ^f   Alvaros J ^f   Montero, M ^f  

^a Medical Service   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c Health Program   (Spain)

^d Municipal Program Against Drug Use   (Spain)

^e Men's Penitentiary Center

^f Maintenance Methadone Programs B ^*

Author keywords

Adherence; Compliance; Directly observed therapy; Human immunodeficiency virus; Treatment; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PRISONER; REGRESSION ANALYSIS; SPAIN; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PRISONERS; PROGRAM DEVELOPMENT; RISK FACTORS; SPAIN; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS;

EID: 0031751796     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040967     Document Type: Article

References (33)

1. Bellin E, Fletcher D, Safyer S. Abnormal chest X-rays in intravenous drug users: implications for tuberculosis screening programs. Am J Public Health 1993; 83: 35-40.
2. Salive ME, Viahov D, Brewer TF. Coinfection with tuberculosis and HIV-1 in male prison inmates. Public Health Rep 1990; 105: 307-310.
3. Grupo de Trabajo sobre Tuberculosis. Conseno Nacional para el control de la tuberculosis en España. Med Clín (Barc) 1992; 98: 24-31.
4. Martín Sánchez M. Programa de Prevención y Control de Enfermedades Transmisibles en instituciones Penitenciarias. Revista de Estudios Penitenciarios. Monográfico de Sanidad Penitenciaria. Madrid-Extra-1-1990; pp. 51-67.
5. Reichman LB, Felton ChP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med 1979; 139: 337-339.
6. March A, Martin V, Garrote G. SIDA y población reclusa en España. Jano 1996; 50: 36-41.
7. Martín V, González P, Caylà JA, et al. Case-finding of pulmonary tuberculosis on admission to a penitentiary centre. Tuberc Lung Dis 1994; 75: 49-53.
8. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol 1994; 140: 113-122.
9. Centers for disease Control and Prevention. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. Morb Mortal Wkly Rep 1989; 18: 313-321.
10. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep 1994; 109: 319-327.
11. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
12. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuberc Lung Dis 1993; 74: 32-37.
13. WHO. Framework for effective tuberculosis control. WHO/TB/1994; 179: 1-13.
14. Epidemiological graphics, estimation and testing package (EGRET). Seattle, WA, Statistics and Epidemiology Research Corperation, 1990.
15. World Health Organization. WHO report on the tuberculosis epidemic 1997. Geneva: World Health Organization, 1997.
16. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
17. Centers for Disease Control and Prevention. Tuberculosis morbidity-United States, 1992. Morb Mortal Wkly Rep 1993; 42: 696-704.
18. World Health Organization. World health statistics annual 1992. Geneva, World Health Organization, 1993.
19. Caminero JA. Tuberculosis and respiratory infections scientific area (SEPAR). Update of the infection and tuberculosis disease in Spain (1988-1992). Tuberc Lung Dis 1994; 75: Suppl., 69-70.
20. Caylà JA, Galdós-Tangüis, García de Olalla P, Brugal T, Jansà JM, Miranda PSC. La Tuberculosis en Barcelona. Informe 1994. Barcelona, Publicaciones del instituto Municipal de la Salud, 1995.
21. Pozsic CJ. Compliance with tuberculosis therapy. Med Clin North Am 1993; 77: 1289-1301.
22. Frieden TR, Sterling T, Pablos-Méndez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
23. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
24. Centers for Disease Control and Prevention. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system. New York, 1991. Morb Mortal Wkly Rep 1992; 41: 507-509.
25. Wright EC. Non compliance. Or how many aunts has Matilda? Lancet 1993; 342: 909-913.
26. Yew WW, Chau C-H, Tse L-S. Does hospitalizing patients with tuberculosis ensure compliance with drug regimens? Clin Infect Dis 1994; 19: 554-555.
27. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City. Turning the tide. N Engl J Med 1995; 333: 229-233.
28. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
29. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951.
30. Gourevitch MN, Wasserman W, Panero MS, Selwin PA. Successful adherence to observed prohylaxis and treatment of tuberculosis among drug users in a methadone program. J Addict Dis 1996; 15: 93-104.
31. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
32. Cooper JR. Methadone treatment and acquired immunodeficiency syndrome. JAMA 1989; 262: 1664-1668.
33. Selwin PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and morality among intravenous drug users in a New York city methadone maintenance program. Am J Public Health 1989; 79: 1358-1362.